Systems

When you partner with 3M Drug Delivery Systems, we develop a customized plan that meets your requirements for a technically and commercially viable product for global marketing. We’ve developed a New Product Introduction (NPI) process to help bring your product to market in a timely, cost-effective manner. Lean Six Sigma methodology helps drive improvements while further reducing timelines.

3M offers a free of charge, no obligation paper feasibility service which explores the likelihood of success of your candidate molecules being delivered by transdermal drug delivery. This offer is open to new chemical entities (NCE) or existing molecules (for life cycle management options). Contact us for more information.

3M has a long history of adhesive technology experience. This expertise combined with our pharmaceutical and formulation development expertise, allows us to customize a solution for your molecule’s specific profile. We begin the development process by working with you to determine the feasibility of transdermal delivery solutions for your molecule.

3M has optimized our feasibility evaluation method for passive TDD systems. By utilizing in-vitro/in-vivo data correlations we can expedite the selection of formulation excipients and minimize the time and cost associated with determining suitability of a drug molecule for transdermal delivery. With our multi-disciplined approach to overall development, we can simultaneously develop the product and process understanding necessary to create a strategy for commercial scale-up, further compressing the timeline.

Our global manufacturing facilities have the capacity to produce large volumes of patches each year, assuring your needs can be met now and into the future.

We understand the complexities of getting regulatory approval and can supply the data, documentation and support you need to speed the process and avoid problems.